# Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines

> **NCT06091410** · PHASE4 · UNKNOWN · sponsor: **Catholic Kwandong University** · enrollment: 62 (actual)

## Conditions studied

- COVID-19
- Influenza
- Vaccine Reaction
- Contaminant Injected

## Interventions

- **BIOLOGICAL:** Omicron-containing COVID-19 vaccine
- **BIOLOGICAL:** influenza vaccine

## Key facts

- **NCT ID:** NCT06091410
- **Lead sponsor:** Catholic Kwandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-25
- **Primary completion:** 2025-02-25
- **Final completion:** 2025-06-25
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2024-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06091410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06091410, "Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06091410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*